[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-368875-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-368875-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","plasma-cytokine-profiles-in-oral-and-oropharyngeal-squamous-cell-carcinoma-research-article","Plasma cytokine profiles in oral and oropharyngeal squamous cell carcinoma - Research article","","Head and neck cancers, including oral and oropharyngeal squamous cell carcinomas (SCC), create major global health burdens. This study evaluates plasma cytokine profiles in patients with oral or oropharyngeal SCC versus healthy donors to identify candidate diagnostic biomarkers. Plasma from healthy donors and cancer patients was analyzed with LEGENDplex multiplex assays to quantify 49 cytokines and inflammatory proteins. Results highlight distinct dysregulation patterns linked to early detection potential.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/plasma-cytokine-profiles-in-oral-and-oropharyngeal-squamous-cell-carcinoma-research-article/368875/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/plasma-cytokine-profiles-in-oral-and-oropharyngeal-squamous-cell-carcinoma-research-article/368875.png","ImageObject",300,407,{"name":42,"@type":43},"Ben ","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-28","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the purpose of this study on cytokines in SCC?","Question",{"text":63,"@type":64},"To evaluate plasma cytokine profiles in oral and oropharyngeal squamous cell carcinoma patients versus healthy donors, aiming to explore potential diagnostic biomarkers.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were plasma cytokines measured in the study?",{"text":68,"@type":64},"Plasma samples from healthy donors and cancer patients were analyzed using LEGENDplex™ multiplex assays to quantify 49 cytokines and inflammatory proteins.",{"name":70,"@type":61,"acceptedAnswer":71},"Which cytokine or protein markers showed diagnostic potential?",{"text":72,"@type":64},"sFasL was downregulated in cancer patients, while PECAM-1, FGF-basic, EPO, PDGF-AA, and PDGF-BB were upregulated, with combined PDGF-AA and PDGF-BB showing high sensitivity for oral cancer.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},368875,1790219456,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":113,"preview_page_count":33,"preview_urls":145},2336478951081,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Mahattanasakul et al. BMCOral Health (2025) 25:1520 BMC Oral Health  \n[https://doi.org/10.1186/s12903-025-06942-y](https://doi.org/10.1186/s12903-025-06942-y)  \nRESEARCH Open Access  \nPlasma cytokine profiles in oral   \nand oropharyngeal squamous cell carcinoma  \nPatnarin Mahattanasakul 1,2, Komkrit Ruangritchankul3,4, Areeya Diloktaweewattana5, Supranee Buranapraditkun6,7* and Nakarin Kitkumthorn8*  \nAbstract  \nBackground Head and neck cancers, including oral and oropharyngeal squamous cell carcinomas (SCC), impact significant global health challenges. This study aimed to evaluate plasma cytokine profiles in patients with oral and oropharyngeal SCC compared to healthy donors to explore potential diagnostic biomarkers.  \nMethods Plasma samples from 18 healthy donors, 11 oral cancer patients, and 11 oropharyngeal cancer patients were analysed using LEGENDplex™ multiplex assays to quantify 49 cytokines and inflammatory proteins. Statistical analysis, including Mann-Whitney U test and ROC curve analysis, was performed to assess diagnostic utility.  \nResults sFasL levels were significantly downregulated in cancer patients, whereas PECAM-1, FGF-basic, EPO,  \nPDGF-AA, and PDGF-BB levels were upregulated. Combined analysis of PDGF-AA and PDGF-BB achieved a sensitivity of 98 . 38% and specificity of 73 . 87% for oral cancer diagnosis. PECAM-1 demonstrated 100% sensitivity for detecting oropharyngeal cancer.  \nConclusion These preliminary findings suggest that alterations in plasma levels of sFasL, PECAM-1, FGF-basic, EPO, PDGF-AA, and PDGF-BB suggest their potential as early diagnostic markers for oral and oropharyngeal SCC. Larger cohort studies are warranted to validate these findings and to develop screening strategies for head and neck cancers.  \nTrial registration The study protocol was approved by the Institutional Review Board of the Faculty of Medicine, Chulalongkorn University (IRB 810/62, Bangkok, Thailand) and adhered to the Declaration of Helsinki. Written informed consent was obtained from all participants.  \nKeywords Oral cancer, Oropharyngeal cancer, Cytokines, Inflammation, Biomarkers  \n*Correspondence: Supranee Buranapraditkun[bsuprane2001@yahoo.com](bsuprane2001@yahoo.com)[ ](bsuprane2001@yahoo.com)Nakarin Kitkumthorn [nakarinkit@gmail.com](nakarinkit@gmail.com)  \n1Department of Otolaryngology, Head and Neck Surgery, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand 2Department of Otolaryngology, Head and Neck Surgery, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok 10330, Thailand  \n3Department of Pathology, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand  \n4Precision Pathology of Neoplasia Research Unit, Department of Pathology, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand  \n5Therapeutic Cell Production Unit, Research Department, Faculty of Medicine Siriraj Hospital, Mahidol University, 10700 Bangkok, Thailand 6Division of Allergy and Clinical Immunology, Department of  \nMedicine, King Chulalongkorn Memorial Hospital, Faculty of Medicine, Chulalongkorn University, Thai Red Cross Society, 10330 Bangkok, Thailand  \n7Faculty of Medicine, Center of Excellence in Vaccine Research and Development (Chula Vaccine Research Center-Chula VRC), Chulalongkorn University, 10330 Bangkok, Thailand  \n8Department of Oral Biology, Faculty of Dentistry, Mahidol University, Yothi Road, 10400 Bangkok, Thailand  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of ","cbCaiiRnkiLiKDek","https://ap.wps.com/l/cbCaiiRnkiLiKDek","pdf",2972962,12,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction\n## Epidemiology and clinical impact\n## Histopathology and current therapies\n## Immunotherapy context\n# Table 1 Clinical and pathological parameters","[{\"question\":\"What was the purpose of this study on cytokines in SCC?\",\"answer\":\"To evaluate plasma cytokine profiles in oral and oropharyngeal squamous cell carcinoma patients versus healthy donors, aiming to explore potential diagnostic biomarkers.\"},{\"question\":\"How were plasma cytokines measured in the study?\",\"answer\":\"Plasma samples from healthy donors and cancer patients were analyzed using LEGENDplex™ multiplex assays to quantify 49 cytokines and inflammatory proteins.\"},{\"question\":\"Which cytokine or protein markers showed diagnostic potential?\",\"answer\":\"sFasL was downregulated in cancer patients, while PECAM-1, FGF-basic, EPO, PDGF-AA, and PDGF-BB were upregulated, with combined PDGF-AA and PDGF-BB showing high sensitivity for oral cancer.\"}]","Plasma cytokine profiles in oral and oropharyngeal squamous cell carcinoma - Research article | PDF",1790179031,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c46870a05cdf9777b3681fe7802d5d33.webp",983,1310,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a8190a522f96f2599e06271483aea5a4.webp",982,1309,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c4139e3b92a5c239877111b1aa024a08.webp",981,1308,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/75d55151a6f36335b4fb17b5a5be2d2d.webp",980,1306]